Details of the Drug
General Information of Drug (ID: DM06TZN)
| Drug Name |
2-methyl-9H-carbazole
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2-METHYLCARBAZOLE; 2-Methyl-9H-carbazole; 9H-Carbazole, 2-methyl-; 3652-91-3; 2-Methyldibenzopyrrole; Carbazole, 2-methyl-; UNII-7MWG08F2MG; 7MWG08F2MG; CHEMBL1173640; PWJYOTPKLOICJK-UHFFFAOYSA-N; 2-methyl carbazole; NSC10153; EINECS 222-894-3; NSC 10153; 2-methyl-9H-carbazol; ACMC-1AHNQ; AC1L2DUH; 2-Methyl-9H-carbazole #; SCHEMBL607346; Carbazole, 2-methyl- (8CI); DTXSID9073963; CTK1C3104; MolPort-006-115-551; ZINC1706058; 9H-Carbazole, 2-methyl- (9CI); FCH838910; NSC-10153; BDBM50322581; AKOS006274371; ACM3652913; KB-25102; OR340083
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 181.23 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 4.1 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 0 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


